Clearside “Tybee” CLS1004-201

Currently Enrolling

A Phase II, randomized, masked, controlled trial to study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunction with Intravitreal Aflibercept in patients with Diabetic Macular Edema.

Duration: 24 weeks

This entry was posted in Uncategorized. Bookmark the permalink.